Advertisement
Mayo Clinic Proceedings Home

Distinct Uric Acid Trajectories Are Associated With Different Risks of Incident Hypertension in Middle-Aged Adults

      Abstract

      Objectives

      To identify common uric acid (UA) trajectories in middle-aged adults and to examine their association with the risk of hypertension.

      Patients and Methods

      This prospective cohort included 5758 participants who were aged between 30 and 60 years without hypertension on or before June 1, 2011. Latent mixture modeling was used to identify UA trajectories from June 1, 2005, through June 1, 2011, as the predictor. Incident hypertension from June 1, 2011, through June 1, 2017, was used as the outcome.

      Results

      We detected 5 distinct trajectory groups of UA in both men and women: low-stable (for women, n=720 [24.6%]; for men, n=732 [25.9%]), low-increasing (for women, n=599 [20.4%]; for men, n=696 [24.6%]), moderate-increasing (for women, n=660 [22.5%]; for men, n=634 [22.4%]), high-decreasing (for women, n=314 [10.7%]; for men, n=227 [8.0%]), and high-stable (for women, n=638, 21.8 %; for men, n=538, 19.0%). We observed that 284 women developed hypertension during a median follow-up of 5.9 years (range, 0.8-6.2 years) and 674 men developed hypertension during a median follow-up of 5.9 years (range, 0.7-6.2 years). Compared with the low-stable group, the moderate-increasing group had the highest risk, with adjusted hazard ratios (HRs) of 2.48 (95% CI, 1.64-3.74) in women and 1.84 (95% CI, 1.43-2.35) in men, followed by the high-stable group, with adjusted HRs of 1.97 (95% CI, 1.29-3.01) in women and 1.45 (95% CI, 1.15-1.88) in men. Notably, the low-increasing group with UA in the normal range also exhibited an increased risk, with adjusted HRs of 1.83 (95% CI, 1.20-2.79) in women and 1.42 (95% CI, 1.10-1.83) in men. The high-decreasing group did not exhibit a substantially increased risk. These observed associations between UA trajectories and hypertension were independent of concurrent weight change.

      Conclusion

      Our results suggest that distinct trajectories of UA are differently associated with hypertension risk in middle-aged adults.

      Abbreviations and Acronyms:

      BMI (body mass index), UA (uric acid)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Mayo Clinic Proceedings
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Sundström J.
        • Sullivan L.
        • D’Agostino R.B.
        • Levy D.
        • Kannel W.B.
        • Vasan R.S.
        Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence.
        Hypertension. 2005; 45: 28-33
        • Perlstein T.S.
        • Gumieniak O.
        • Williams G.H.
        • et al.
        Uric acid and the development of hypertension: the normative aging study.
        Hypertension. 2006; 48: 1031-1036
        • Mellen P.B.
        • Bleyer A.J.
        • Erlinger T.P.
        • et al.
        Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study.
        Hypertension. 2006; 48: 1037-1042
        • Krishnan E.
        • Kwoh C.K.
        • Schumacher H.R.
        • Kuller L.
        Hyperuricemia and incidence of hypertension among men without metabolic syndrome.
        Hypertension. 2007; 49: 298-303
        • Grayson P.C.
        • Kim S.Y.
        • LaValley M.
        • Choi H.K.
        Hyperuricemia and incident hypertension: a systematic review and meta-analysis.
        Arthritis Care Res (Hoboken). 2011; 63: 102-110
        • Forman J.P.
        • Choi H.
        • Curhan G.C.
        Plasma uric acid level and risk for incident hypertension among men.
        J Am Soc Nephrol. 2007; 18: 287-292
        • Sung K.C.
        • Byrne C.D.
        • Ryu S.
        • et al.
        Baseline and change in uric acid concentration over time are associated with incident hypertension in large Korean cohort.
        Am J Hypertens. 2017; 30: 42-50
        • Palmer T.M.
        • Nordestgaard B.G.
        • Benn M.
        • et al.
        Association of plasma uric acid with ischaemic heart disease and blood pressure: Mendelian randomisation analysis of two large cohorts.
        BMJ. 2013; 347: f4262
        • Stevens L.A.
        • Claybon M.A.
        • Schmid C.H.
        • et al.
        Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities.
        Kidney Int. 2011; 79: 555-562
        • Jones B.L.
        • Nagin D.S.
        • Roeder K.
        A SAS procedure based on mixture models for estimating developmental trajectories.
        Sociol Methods Res. 2001; 29: 374-393
        • Feig D.I.
        • Kang D.H.
        • Johnson R.J.
        Uric acid and cardiovascular risk.
        N Engl J Med. 2008; 359: 1811-1821
        • Zhou B.
        • Cooperative Meta-Analysis Group of the Working Group on Obesity in China
        Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults—study on optimal cut-off points of body mass index and waist circumference in Chinese adults.
        Biomed Environ Sci. 2002; 15: 83-96
        • Nagin D.S.
        Group-Based Modeling of Development.
        Harvard University Press, Cambridge, MA2005
        • Nagin D.S.
        Group-based trajectory modeling: an overview.
        Ann Nutr Metab. 2014; 65: 205-210
        • Jones B.L.
        • Nagin D.S.
        Advances in group-based trajectory modeling and an SAS procedure for estimating them.
        Sociol Methods Res. 2007; 35: 542-571
        • Johnson R.J.
        • Kang D.H.
        • Feig D.
        • et al.
        Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease.
        Hypertension. 2003; 41: 1183-1190
        • Mazzali M.
        • Kanellis J.
        • Han L.
        • et al.
        Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism.
        Am J Physiol Renal Physiol. 2002; 282: F991-F997
        • Sánchez-Lozada L.G.
        • Soto V.
        • Tapia E.
        • et al.
        Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia.
        Am J Physiol Renal Physiol. 2008; 295: F1134-F1141
        • Khosla U.M.
        • Zharikov S.
        • Finch J.L.
        • et al.
        Hyperuricemia induces endothelial dysfunction.
        Kidney Int. 2005; 67: 1739-1742
        • Rao G.N.
        • Corson M.A.
        • Berk B.C.
        Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression.
        J Biol Chem. 1991; 266: 8604-8608
        • Soletsky B.
        • Feig D.I.
        Uric acid reduction rectifies prehypertension in obese adolescents novelty and significance.
        Hypertension. 2012; 60: 1148-1156
        • Feig D.I.
        • Soletsky B.
        • Johnson R.J.
        Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial.
        JAMA. 2008; 300: 924-932
        • Feig D.I.
        Uric acid: a novel mediator and marker of risk in chronic kidney disease.
        Curr Opin Nephrol Hypertens. 2009; 18: 526-530
        • Watanabe S.
        • Kang D.
        • Feng L.
        • et al.
        Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity.
        Hypertension. 2002; 40: 355-360
        • Masuo K.
        • Kawaguchi H.
        • Mikami H.
        • Ogihara T.
        • Tuck M.L.
        Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation.
        Hypertension. 2003; 42: 474-480
        • Johnson R.J.
        • Perez-Pozo S.E.
        • Sautin Y.Y.
        • et al.
        Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes.
        Endocr Rev. 2009; 30: 96-116
        • Parsa A.
        • Brown E.
        • Weir M.R.
        • et al.
        Genotype-based changes in serum uric acid affect blood pressure.
        Kidney Int. 2012; 81: 502-507
        • Johnson R.J.
        • Titte S.
        • Cade J.R.
        • Rideout B.A.
        • Oliver W.J.
        Uric acid, evolution and primitive cultures.
        Semin Nephrol. 2005; 25: 3-8
        • Johnson R.J.
        • Nakagawa T.
        • Sanchez-Lozada L.G.
        • et al.
        Sugar, uric acid, and the etiology of diabetes and obesity.
        Diabetes. 2013; 62: 3307-3315